Tirzepatide Added to Restricted Drug List Following a review of the clinical use of Injectable GLP-1 Receptor Agonists for obesity and Type-2 Diabetes Mellitus, the Ministry has approved the inclusion of Injection Tirzepatide (Mounjaro) in the CGHS Online List of Restricted Drugs
The right timing depends on your current dose, side effect history, and how sensitive you are to gastrointestinal symptoms
Rinse abundantly with water and repeat if necessary
Over time, reduced glucose variability and improved hormonal balance help lessen insulin resistance symptoms
Our meal plans are built around nutrient-dense, high-protein foods that help you get what your body needs, even when your appetite is working against you
Given the role of PYY in appetite suppression it is thought that disturbances in PYY release in response to food intake may play a role in the development of obesity